ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag genome architecture disease medicine neuroscience

Haydeh Payami is wearing a purple dress and an orange and pink scarf and standing in front of a whiteboard.
A Microbial Link to Parkinson’s Disease
Mariella Bodemeier Loayza Careaga, PhD | Dec 4, 2023 | 6 min read
Haydeh Payami helped uncover the genetic basis of Parkinson’s disease. Now, she hopes to find new ways to treat the disease by studying the gut microbiome.
A rendering of a human brain in blue on a dark background with blue and white lines surrounding the brain to represent the construction of new connections in the brain.
Defying Dogma: Decentralized Translation in Neurons
Danielle Gerhard, PhD | Sep 8, 2023 | 10+ min read
To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
New companies to commercialise neuroscience discoveries
John Borchardt | Nov 2, 2000 | 4 min read
Neurogenomics has significant commercial potential by way of gene targets for enhancement of brain function and treatment of brain-based disease.
GWAS, psychotic disorder, mood disorder, Q&A, bipolar disorder, schizophrenia, depression, sex differences
Genetic Variants Tied to Sex Differences in Psychiatric Disorders
Amanda Heidt | Mar 31, 2021 | 5 min read
The largest study of its kind identifies single nucleotide polymorphisms with disparate effects on men’s and women’s susceptibility to conditions such as bipolar disorder and schizophrenia.
Analysis of 2,000 Brains Provides Clues to Schizophrenia, Autism
Catherine Offord | Dec 14, 2018 | 2 min read
The PsychENCODE project delves into the DNA, RNA, and protein changes related to brain development and neuropsychiatric disorders, but researchers caution it’s just a first step toward treatment.
Schizophrenia and the Synapse
Ruth Williams | Jan 27, 2016 | 3 min read
Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Research Notes
Ricki Lewis | Apr 16, 2000 | 3 min read
Fly Model of Parkinson's Disease With genome projects finishing at an ever quickening pace, many new animal models of human disease are being developed. A very promising one is a Drosophila version of Parkinson's disease (M.B. Feany and W.B. Bender, "A Drosophila model of Parkinson's disease," Nature, 404:394-8, March 23, 2000). At Harvard Medical School, Mel Feany, an instructor in pathology, and Welcome Bender, a professor of biological chemistry and molecular pharmacology, created flies trans

Run a Search

ADVERTISEMENT